EAM
Eventide Asset Management Portfolio holdings
AUM
$5.71B
This Quarter Return
+9.88%
1 Year Return
+51.18%
3 Year Return
+209.28%
5 Year Return
+283.63%
10 Year Return
+1,480.39%
AUM
$5.45B
AUM Growth
+$5.45B
(+7.5%)
Cap. Flow
+$45.9M
Cap. Flow
% of AUM
0.84%
Top 10 Holdings %
Top 10 Hldgs %
26.99%
Holding
160
New
17
Increased
65
Reduced
42
Closed
14
Top Buys
| 1 |
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
|
$43.8M |
| 2 |
Doximity
DOCS
|
$42.6M |
| 3 |
Palo Alto Networks
PANW
|
$30.3M |
| 4 |
Lithia Motors
LAD
|
$28.7M |
| 5 |
Sarepta Therapeutics
SRPT
|
$25.8M |
Top Sells
| 1 |
GTM
ZoomInfo Technologies
GTM
|
$79.2M |
| 2 |
DoubleVerify
DV
|
$40.7M |
| 3 |
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
|
$38.9M |
| 4 |
Immunovant
IMVT
|
$35.7M |
| 5 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
$32.7M |
Sector Composition
| 1 | Healthcare | 43.08% |
| 2 | Technology | 24.5% |
| 3 | Industrials | 13.06% |
| 4 | Consumer Discretionary | 7.01% |
| 5 | Utilities | 3.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Sherwin-Williams
SHW
$90.3B
| $14.6M | 0.27% |
64,734
+11,287
| +21% | +$2.54M |
|
102
Akero Therapeutics
AKRO
$3.62B
| $14.5M | 0.27% |
+379,120
| New | +$14.5M |
|
103
Ultragenyx Pharmaceutical
RARE
$3.06B
| $14.4M | 0.26% |
359,000
| – | – |
|
104
IDEX
IEX
$12.1B
| $14.1M | 0.26% |
61,154
-8,003
| -12% | -$1.85M |
|
105
Beam Therapeutics
BEAM
$1.86B
| $14.1M | 0.26% |
459,203
+192,178
| +72% | +$5.88M |
|
|
AESC
106
DELISTED
The AES Corporation
AESC
| – | – |
-171,200
| Closed | -$17.5M |
|
|
MRTX
107
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $13.8M | 0.25% |
371,102
+167,502
| +82% | +$6.23M |
|
108
Neurocrine Biosciences
NBIX
$13.6B
| $13.7M | 0.25% |
135,000
| – | – |
|
109
Amylyx Pharmaceuticals
AMLX
$878M
| $13.4M | 0.25% |
458,054
+208,054
| +83% | +$6.1M |
|
110
Element Solutions
ESI
$6.06B
| $13.4M | 0.25% |
693,556
-277,444
| -29% | -$5.36M |
|
111
ZipRecruiter
ZIP
$441M
| $13M | 0.24% |
+817,475
| New | +$13M |
|
112
Keros Therapeutics
KROS
$642M
| $12.8M | 0.24% |
+300,000
| New | +$12.8M |
|
113
Roivant Sciences
ROIV
$8.6B
| $12.5M | 0.23% |
1,690,300
| – | – |
|
114
GXO Logistics
GXO
$5.83B
| $11.1M | 0.2% |
220,075
+75
| +0% | +$3.79K |
|
115
Encompass Health
EHC
$12.4B
| $10.3M | 0.19% |
189,979
-4,516
| -2% | -$244K |
|
116
89bio
ETNB
$1.36B
| $9.78M | 0.18% |
+642,073
| New | +$9.78M |
|
|
APTV.PRA
117
DELISTED
Aptiv PLC 5.50% Series A Mandatory Convertible Preferred Shares
APTV.PRA
| – | – |
0
| – | – |
|
118
BioCryst Pharmaceuticals
BCRX
$1.71B
| $9.2M | 0.17% |
+1,102,889
| New | +$9.2M |
|
|
RCM
119
DELISTED
R1 RCM Inc. Common Stock
RCM
| $8.93M | 0.16% |
+595,569
| New | +$8.93M |
|
120
WEC Energy
WEC
$34.2B
| $8.93M | 0.16% |
94,165
-86,027
| -48% | -$8.15M |
|
|
CERE
121
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $7.61M | 0.14% |
+312,000
| New | +$7.61M |
|
122
Denali Therapeutics
DNLI
$2.25B
| $7.22M | 0.13% |
+313,407
| New | +$7.22M |
|
123
Annexon
ANNX
$231M
| $7.19M | 0.13% |
1,867,250
-1,759,258
| -49% | -$6.77M |
|
124
Crinetics Pharmaceuticals
CRNX
$3.2B
| $6.98M | 0.13% |
+434,768
| New | +$6.98M |
|
125
CMS Energy
CMS
$21.4B
| $6.91M | 0.13% |
112,531
-82,969
| -42% | -$5.09M |
|